Skip over main navigation
  • Sign up
  • Log in
  • Basket: (0 items)
Association of Medical Research Charities
  • Twitter
  • Linkedin
  • YouTube
Contact us Donate
Menu
  • About us
    • Who we are
    • Our team
    • Governance
    • Networks and groups
  • Our members
    • Sector infographics and reports
    • Become a member
    • Member benefits
    • Member directory
  • Our guidance
    • Research management
    • Partnering for patients
    • Research impact
    • Future trends
    • Digital health ethics
    • IP
  • Our views
    • Position statements and briefings
    • Consultation responses
    • APPG on Medical Research
    • Leaving the EU
    • Research in the NHS
    • Patient data
    • Charity Research Support Fund (CRSF)
  • Our supporters
    • Become a supporter
    • Our supporters
  • What's happening
    • Peer review audit 2020
    • AMRC Open Research
    • Events
    • News
    • Blogs
    • Vacancies
  • Admin
    • Log in
  • Basket: (0 items)
  • Leaving the EU

Leaving the EU

Negotiations continue to determine the UK’s new relationship with the EU. We are working to ensure that the voice of the medical research charity sector is heard as part of the process.

No negative impact on patients

Our member charities agree that it’s vital for the deal reached to ensure there is no negative impact on patients. This applies both within the UK and across the EU.

This means patients must be able to continue to:

  • Participate in vital pan-EU clinical trials
  • Have speedy access to new medical innovations
  • Experience no disruption in the supply of medicines and treatments
  • Benefit from the fruits of innovative research collaborations across the UK and EU [read this report about the importance of international collaboration]

We are working with key stakeholders to ensure:

  • The UK is positioned as an attractive destination for global research talent and expertise
  • An aligned and compatible regulatory framework is implemented between the UK and the EU for medical research
  • The European Medicines Agency on EU regulatory frameworks and agreements for medicines and medical devices confirms patients will have timely access to new health innovations
  • Continued participation in EU funding programmes and collaborative opportunities to progress the discovery and understanding of disease and ill health.
  • No disruptions to the supply and trade of medicine and other health technologies from day on of the UK’s new relationship with the EU.

Brexit Health Alliance

We’re a member of the Brexit Health Alliance, which brings together the NHS, medical research, industry, patients and public health organisations to safeguard the interests of patients, and the healthcare and research they rely on during the Brexit negotiations.

We’ve published several position statements and consultations responses related to leaving the EU.

Published: 2nd November, 2017

Updated: 18th March, 2020

Author:

Share this page
  • Email
  • Facebook
  • Twitter

Latest

  • Mesothelioma UK

    Mesothelioma UK

    Mesothelioma UK funds research into asbestos-related cancer, mesothelioma

  • Charity-funded #ResearchAtRisk

    Charity-funded #ResearchAtRisk

  • The people behind the charities

    The people behind the charities

  • Dr Sonya Babu-Narayan

    Elected AGM 2018

Most read

  • Who we are

    We are a membership organisation for over 140 medical research charities across the UK. We support them in saving and improving lives through research and innovation.

  • Vacancies

    Vacancies

  • Changes to the way Excess Treatment Costs (ETCs) are paid

    Changes to the way Excess Treatment Costs (ETCs) are paid

  • Principles of peer review

    Principles of peer review

  • Become a member

    Become a member

    Join us and become part of a network of 150 medical and health research charities who deliver high-quality research that saves and improves lives

  • Leaving the EU

    Leaving the EU

    Negotiations continue to determine the UK’s new relationship with the EU. We are working to ensure that the voice of the medical research charity sector is heard as part of this process

  • Aisling Burnand

    Chief Executive - Phone: 020 8078 6042 - Email: [email protected]

  • Become a supporter

    Become a supporter

    You don’t have to be a member charity to get involved with our work

  • Facilitating adoption of off-patent, repurposed medicines into NHS clinical practice

    Facilitating adoption of off-patent, repurposed medicines into NHS clinical practice

  • Consultation on revised AMRC IP guidance

    Consultation on revised AMRC IP guidance

Contact us

AMRC is a registered charity in England and Wales (296772). Registered as a company limited by guarantee (2107400) in England and Wales.

AMRC
99 Gray's Inn Road
London WC1X 8TY, UK

General enquiries: 020 8078 6042; [email protected]
Press enquiries: 020 8078 6044; [email protected] 

  • Sitemap
  • Accessibility
  • Terms & Conditions
  • Privacy Notice
  • Complaints
  • Disclaimer
  • Twitter
  • Linkedin
  • YouTube

Copyright © 2017 AMRC. All rights reserved.


AMRC is a registered charity in England and Wales (296772). 

Registered as a company limited by guarantee (2107400) in England and Wales.
Registered office at 99 Gray's Inn Rd, London WC1X 8TY.

© 2019 AMRC. All rights reserved.